# Ondansetron

NDC: 51655-196
Generic name: Ondansetron
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20220720

FDA application: ANDA090469

## Active ingredients

- ONDANSETRON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-196"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-196
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2b502e2-03ed-fe5c-e053-2995a90a368e